UroGen Pharma Says FDA Approves Plan For Rolling NDA Submission For UGN-102 From January 2024

RTTNews | hace 757
UroGen Pharma Says FDA Approves Plan For Rolling NDA Submission For UGN-102 From January 2024

(RTTNews) - Biotech company UroGen Pharma Ltd. (URGN) announced Tuesday that it has reached agreement with the U.S. Food and Drug Administration (FDA) on plans for submission of a New Drug Application (NDA) for UGN-102 (mitomycin) for intravesical solution.

The FDA indicated that the current clinical development plan for UGN-102, which includes evaluation of duration of complete response (CR) at 12 months from the pivotal ENVISION trial, will support submission of an NDA for the treatment of low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).

The FDA also agreed that the UGN-102 NDA can utilize a rolling review, allowing for early submission of the Chemistry, Manufacturing and Controls (CMC) sections of the NDA, which is planned for January 2024.

If approved, UGN-102 has the potential to introduce a new non-surgical treatment paradigm for LG-IR-NMIBC, a subset of bladder cancer patients characterized by high recurrence rates and the need for multiple surgeries.

The UGN-102 clinical development plan centers around the Phase 3 ENVISION pivotal trial and is supported by robust clinical data from the ATLAS Phase 3 and OPTIMA Phase 2b trials.

read more
UroGen Pharma Files Patent Infringement Lawsuit Against Teva Pharma

UroGen Pharma Files Patent Infringement Lawsuit Against Teva Pharma

Biotech company UroGen Pharma Ltd. (URGN) announced Wednesday that it has filed a lawsuit in the U.S. District Court for the District of Delaware against Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc., and Teva Pharmaceutical Industries, Ltd. (TEVA), alleging infringement of U.S. Patent Numbers 9,040,074 and 9,950,069.
RTTNews | hace 574
Asian Markets Trade Mostly Higher

Asian Markets Trade Mostly Higher

Asian markets are trading mostly higher on Thursday, following the mixed cues from Wall Street overnight, amid optimism about a potential trade deal between the U.S. and China as US President Donald Trump and Chinese President Xi Jinping meet. Traders also react to another quarter point interest rate cut by the US Fed. Asian markets closed mostly higher on Wednesday.
RTTNews | hace 13 minutos
Japanese Market Modestly Lower

Japanese Market Modestly Lower

The Japanese market is modestly lower in choppy trading on Thursday, reversing some of the sharp gains in the previous session, following the mixed cues from Wall Street overnight. The Nikkei 225 is falling well below the 51,150 level, with weakness in index heavyweights and automaker stocks partially offset by gains in financial and technology stocks.
RTTNews | hace 1h 58min
China Bourse May Slip Beneath 4,000-Point Level

China Bourse May Slip Beneath 4,000-Point Level

The China stock market bounced higher again on Wednesday, one day after ending the three-day winning streak in which it had collected more than 80 points or 2 percent. The Shanghai Composite Index now sits just above the 4,015-point plateau although it may head south again on Thursday.
RTTNews | hace 2h 21min
Australian Market Modestly Lower

Australian Market Modestly Lower

The Australian market is trading modestly lower on Thursday, adding to the losses in the previous two sessions, following the mixed cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling below the 8,900 level, with gains in iron ore miners and financial partially offset by weakness in technology stocks.
RTTNews | hace 2h 28min
Taiwan Bourse May Remain Rangebound On Thursday

Taiwan Bourse May Remain Rangebound On Thursday

The Taiwan stock market has moved higher in two of three trading days since the end of the two-day slide in which it had slumped more than 220 points or 0.8 percent. The Taiwan Stock Exchange now sits just shy of the 28,300-point plateau although it may tick lower again on Thursday.
RTTNews | hace 2h 56min
Singapore Shares May See Continued Consolidation

Singapore Shares May See Continued Consolidation

The Singapore stock market on Wednesday snapped the six-day winning streak in which it had jumped more than 120 points or 2.9 percent. The Straits Times Index now sits just above the 4,440-point plateau and it may take further damage on Thursday.
RTTNews | hace 3h 21min